Related Experiment Video

Updated: Sep 25, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Pre-eclampsia and thrombophilia

Joanne Said1, Gustaaf Dekker

  • 1Department of Perinatal Medicine, The Royal Women's Hospital, Melbourne, Australia. josaid@bigpond.net.au

Best Practice & Research. Clinical Obstetrics & Gynaecology
|June 6, 2003
PubMed

Insights

Thrombophilias, or blood clotting disorders, may increase the risk of pre-eclampsia, a serious pregnancy condition. Further research could lead to new preventive treatments for this condition.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatal Medicine

Background:

  • Pre-eclampsia is a significant global cause of maternal and perinatal mortality.
  • The exact causes of pre-eclampsia are not fully understood, but risk factors are being identified.
  • Thrombophilias are suspected contributors to uteroplacental thrombosis in pre-eclampsia.

Purpose of the Study:

  • To explore the association between thrombophilias and pre-eclampsia.
  • To investigate the potential role of thrombophilias in the development of uteroplacental thrombosis.
  • To identify potential avenues for preventive strategies against pre-eclampsia.

Main Methods:

  • Review of existing studies associating thrombophilias with pre-eclampsia.
  • Biological plausibility assessment of thrombophilias contributing to uteroplacental thrombosis.
  • Exploration of potential preventive treatments based on confirmed associations.

Main Results:

  • A number of studies have suggested an association between thrombophilias and pre-eclampsia.
  • Biological mechanisms support the hypothesis that thrombophilias could cause uteroplacental thrombosis.
  • The confirmation of this association opens possibilities for novel therapeutic interventions.

Conclusions:

  • Thrombophilias represent a potential risk factor for pre-eclampsia.
  • Further investigation into this association is warranted.
  • Preventive treatments like low-molecular-weight heparins, aspirin, and folate may be considered if the link is confirmed.

More Related Videos

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...